MILLENNIUM MANAGEMENT LLC is an investment firm that reports beneficial ownership of shares in Faeth Therapeutics, Inc. (FTH) under U.S. securities law. It has submitted 3 SEC insider filings since 2026, most recently in May 2026.
Every role MILLENNIUM MANAGEMENT LLC has reported on a Form 4, reconstructed from the filings themselves. Reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
Faeth Therapeutics, Inc. (FTH)1 filingUpdated Aug 31, 2026
MILLENNIUM MANAGEMENT LLC is 10% Owner of Faeth Therapeutics, Inc. (FTH). 1 SEC Form 4 filing on record, dated 15 May 2026. Most recent open-market trade: sold $37K of FTH on 15 May 2026. Lifetime open-market purchases: $141K. Lifetime open-market sales: $538K.
Every recent SEC Form 4 transaction MILLENNIUM MANAGEMENT LLC has reported, most recent first.
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realized performance after each tracked open-market purchase.
| Metric | Value |
|---|---|
| Total purchases tracked | 5 |
InsiderAlpha's records for MILLENNIUM MANAGEMENT LLC go back to 2026: 1 primary Form 4 filing, an average of 1.0 per year. The typical open-market purchase is $28K (5 buys totaling $141K). The largest single buy on record is $44K of FTH in 2026. Sales side: 12 recorded sales totaling $538K, so the filing history runs sell-heavy by dollar value. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Insiders who reported open-market trades in the last 12 months at the companies MILLENNIUM MANAGEMENT LLC files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
MILLENNIUM MANAGEMENT LLC is an investment firm, tracked as 10% Owner of Faeth Therapeutics, Inc. (FTH). InsiderAlpha holds 1 primary Form 4 filing for it, the earliest from 2026, updated as new SEC EDGAR filings are processed.
The only primary Form 4 on record is dated 15 May 2026.
Recorded transactions: 5 open-market purchases ($141K) and 12 open-market sales ($538K) across all tracked filings.
Across 5 tracked purchases, MILLENNIUM MANAGEMENT LLC averaged no 30-day data yet with a win rate pending.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
$FTH Faeth Therapeutics, Inc.4.4K shares @ $31.38$139K